ReiThera
Rome, IT
1 confirmed programs
· 1 sponsors
· Last scored 2026-04-29
71.1
Signal Score
○ FDA Inspections
✓ Clinical Trials (1)
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: ReiThera
- Signal Score
- 71.1/100 (as of 2026-04-29)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Rome, IT
- Modalities
- Adenoviral, AAV
- Active Programs
- 1 confirmed from ClinicalTrials.gov across 1 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ReiThera
Italian viral vector CDMO. COVID vaccine development.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
50.0
1 active programs across 1 sponsors
Modalities: Adenoviral, AAV
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: Adenoviral, AAV
Programs
1
Sponsors1
ModalitiesAdenoviral, AAV
1 active programs across 1 sponsors
Modalities: Adenoviral, AAV
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Jul 04, 2026
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
Sites: Rome, Italy
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Rome, Italy
Modalities: Adenoviral, AAV
Capacity assessment: 58.0/100
ReiThera EMA GMP Compliance 4 certificates
2024-11
2024-11
2022-01
2022-01
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/44/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/32/H/2025 | Reithera S.r.l. | Italy | 2024-11-22 | COMPLIANT |
| IT-API/119/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
| IT-API/251/H/2022 | Reithera S.r.l. | Italy | 2022-01-28 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Jul 04, 2026
Frequently Asked Questions About ReiThera
Does ReiThera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for ReiThera.
How many clinical programs is ReiThera linked to?
ReiThera is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is ReiThera's CDMO Signal Score?
ReiThera has a Signal Score of 71/100, based on quality, operations, financial stability, and capacity data.
Evaluating ReiThera for a manufacturing program?
Use the free AI matchmaker to compare ReiThera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Advent Bioservices
London, UK
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Emergent BioSolutions (CGT)
Baltimore, MD
Signal Score: 71.0
AAV, Adenoviral